Page 13 - 2019 UM Dermatology Annual Letter - Pages 121819
P. 13
RESEARCH Annual Letter 2019 | 13
Our research efforts continue to grow with faculty Our current research efforts are led by our 16
participation in numerous NIH grants. Currently, laboratory-based researchers. This growing
18 faculty receive federal research support and vibrant group of scientists provides a unique
our research portfolio includes $9,734,357.95 in research base for our trainees as the Division
new NIH funding. We have 110 funded studies of Research in Skin Biology and Dermatologic
and our total direct and indirect costs represent a Science and the nucleus of our Master’s Program
portfolio of over $27 million in research funding, in Skin Biology and Dermatologic Science, which
including over $14 million in Federal funding of enrolled its third class this past August. Dr. Anna
which $13 million are NIH grants. Our researchers Nichols, co-director of our clinical trials unit,
continue their productivity submitting both exemplifies our growing clinical research efforts
individual and team science grants. Dr. Marjana as she is currently involved in over 20+ clinical
Tomic-Canic exemplifies our research success. research projects, including work on skin cancer
As Vice Chair for Research, Dr. Tomic-Canic is chemoprevention and treatment such as impactful
part of projects funded by over $7 million in NIH studies on vaccines for skin cancer. Our laboratory
grants. Professor Steve Davis has been among our and clinical researchers are all contributing to
most consistent successfully funded researchers paradigm shifting research. As of early December,
focusing on studying wound healing and anti- full time faculty from our Department published
infective drugs and devices that translate science 273 papers in 2019 in peer-reviewed biomedical
into practice. journals. Among the many important papers are
the ones highlighted earlier.
Dr. Barbara Bedogni who studies pathogenesis
and potential treatment for Melanoma and
Dr. Tasuku Akiyama who studies itch, continue
with their NIH funded research. Both have
significantly added to our research environment.
